{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-005210","form_type":"8-K","ticker":"INBS","cik":"0001725430","company_name":"INTELLIGENT BIO SOLUTIONS INC.","filed_at":"2026-02-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.011102+00:00","generated_at":"2026-05-16T04:29:36.117507+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Intelligent Bio sees 48% Q2 revenue growth YoY, H1 revenue tops $2M","bullets":["Fiscal Q2 2026 revenue expected up ~48% YoY; readers more than double (+104% YoY).","H1 2026 total revenue ~$2.01M (+36% YoY); cartridge sales +38%, readers +50%.","CEO cites expanding installed base as foundation for recurring cartridge revenue.","Company expects to file 10-Q for Q2 ended Dec 31, 2025 during week of Feb 9, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-005210","json":"https://secwatch.observer/filing/0001493152-26-005210.json","markdown":"https://secwatch.observer/filing/0001493152-26-005210.md","text":"https://secwatch.observer/filing/0001493152-26-005210.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1725430/000149315226005210/0001493152-26-005210-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1725430/000149315226005210/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T04:29:36.117507+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}